- Report
- February 2025
- 200 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- January 2025
- 175 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- January 2025
- 175 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- January 2025
- 175 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- January 2025
- 175 Pages
Global
From €3995EUR$4,490USD£3,449GBP
- Report
- April 2025
Global
From €4359EUR$4,900USD£3,764GBP
- Report
- August 2025
- 378 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 287 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 181 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 365 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 396 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 267 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 273 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 180 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 243 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 488 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 383 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 376 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 377 Pages
Global
From €5205EUR$5,850USD£4,494GBP
- Report
- August 2025
- 288 Pages
Global
From €5205EUR$5,850USD£4,494GBP

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer.
Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes.
Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more